✦ LIBER ✦

Olmesartan Reducing Incidence of Endstage Renal Disease in Diabetic Nephropathy Trial (ORIENT): Rationale and Study Design

✍ Scribed by IMAI, Enyu; ITO, Sadayoshi; HANEDA, Masakazu; CHAN, Juliana C. N.; MAKINO, Hirofumi

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rationale for and study design of the su

✍ H. J. Lambers Heerspink; M. J. Fowler; J. Volgi; A. T. Reutens; I. Klein; T. A. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB

Rationale, design, and baseline characte

✍ Gilles F.H. Diercks; Wilbert M.T. Janssen; Ad J. van Boven; Annette A.A. Bak; Pa 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Sex differences in the association betwe

✍ Abbasi, A.; Corpeleijn, E.; Meijer, E.; Postmus, D.; Gansevoort, R. T.; Gans, R. 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 169 KB

Rationale and Trial Design of Bardoxolon

✍ de Zeeuw, Dick; Akizawa, Tadao; Agarwal, Rajiv; Audhya, Paul; Bakris, George L.; 📂 Article 📅 2013 🏛 S. Karger AG 🌐 English ⚖ 268 KB

Rationale and study design for a randomi

✍ Emma G Wilmot; Melanie J Davies; Charlotte L Edwardson; Trish Gorely; Kamlesh Kh 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 203 KB